mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.2 |